L L Albers1. 1. University of New Mexico Health Sciences Center, College of Nursing, Albuquerque 87131-1061, USA.
Abstract
OBJECTIVE: To measure the duration of active labor (first and second stages) in low-risk women whom received intrapartum care from certified nurse-midwives in nine hospital settings in the United States in 1996. Clinical factors and morbidity indicators associated with longer labors were also examined. DESIGN: An observational study was conducted with healthy women at term who did not receive oxytocin or epidurals (n = 2511). Descriptive statistics are reported for the duration of the active phase--first stage (4 cm to complete cervical dilatation) and second stage (complete to delivery)--by parity and for subgroups of women according to race/ethnicity, age, insurance, activity in labor, type of fetal heart monitoring, and narcotic analgesia. Logistic regression was also used to assess the contribution of each variable to longer labors with simultaneous adjustment of the other variables. RESULTS: The mean length of the active-phase, first stage was 7.7 hours for nulliparas and 5.6 hours for multiparas (statistical limits of 2 standard deviations from the mean were 17.5 and 13.8 hours, respectively). The mean length of second stage was 54 minutes for nulliparas and 18 minutes for multiparas (statistical limits 146 and 64 minutes, respectively). Variables associated with longer labors were electronic fetal monitoring, ambulation, maternal age over 30 years, and narcotic analgesia. Morbidity was not increased in longer labors. CONCLUSION: Normal labor in healthy women lasted longer than many clinicians expect. The criteria for distinguishing normal from abnormal labor, based on time, need revision.
OBJECTIVE: To measure the duration of active labor (first and second stages) in low-risk women whom received intrapartum care from certified nurse-midwives in nine hospital settings in the United States in 1996. Clinical factors and morbidity indicators associated with longer labors were also examined. DESIGN: An observational study was conducted with healthy women at term who did not receive oxytocin or epidurals (n = 2511). Descriptive statistics are reported for the duration of the active phase--first stage (4 cm to complete cervical dilatation) and second stage (complete to delivery)--by parity and for subgroups of women according to race/ethnicity, age, insurance, activity in labor, type of fetal heart monitoring, and narcotic analgesia. Logistic regression was also used to assess the contribution of each variable to longer labors with simultaneous adjustment of the other variables. RESULTS: The mean length of the active-phase, first stage was 7.7 hours for nulliparas and 5.6 hours for multiparas (statistical limits of 2 standard deviations from the mean were 17.5 and 13.8 hours, respectively). The mean length of second stage was 54 minutes for nulliparas and 18 minutes for multiparas (statistical limits 146 and 64 minutes, respectively). Variables associated with longer labors were electronic fetal monitoring, ambulation, maternal age over 30 years, and narcotic analgesia. Morbidity was not increased in longer labors. CONCLUSION: Normal labor in healthy women lasted longer than many clinicians expect. The criteria for distinguishing normal from abnormal labor, based on time, need revision.
Authors: Anna C McCormick; Jennifer J McIntosh; Weihua Gao; Judith U Hibbard; Meredith O Cruz Journal: Am J Perinatol Date: 2019-06-14 Impact factor: 1.862
Authors: Jeremy L Neal; Nancy K Lowe; Karen L Ahijevych; Thelma E Patrick; Lori A Cabbage; Elizabeth J Corwin Journal: J Midwifery Womens Health Date: 2010 Jul-Aug Impact factor: 2.388
Authors: Logan G Spector; Sharon E Murphy; Katherine M Wickham; Bruce Lindgren; Anne M Joseph Journal: Pediatrics Date: 2014-05-12 Impact factor: 7.124
Authors: Jeremy L Neal; Jane M Lamp; Jacalyn S Buck; Nancy K Lowe; Shannon L Gillespie; Sharon L Ryan Journal: J Midwifery Womens Health Date: 2014-02-11 Impact factor: 2.388
Authors: Nathan Gold; Martin G Frasch; Christophe L Herry; Bryan S Richardson; Xiaogang Wang Journal: Front Physiol Date: 2018-01-05 Impact factor: 4.566
Authors: Olufemi T Oladapo; Joao Paulo Souza; Bukola Fawole; Kidza Mugerwa; Gleici Perdoná; Domingos Alves; Hayala Souza; Rodrigo Reis; Livia Oliveira-Ciabati; Alexandre Maiorano; Adesina Akintan; Francis E Alu; Lawal Oyeneyin; Amos Adebayo; Josaphat Byamugisha; Miriam Nakalembe; Hadiza A Idris; Ola Okike; Fernando Althabe; Vanora Hundley; France Donnay; Robert Pattinson; Harshadkumar C Sanghvi; Jen E Jardine; Özge Tunçalp; Joshua P Vogel; Mary Ellen Stanton; Meghan Bohren; Jun Zhang; Tina Lavender; Jerker Liljestrand; Petra Ten Hoope-Bender; Matthews Mathai; Rajiv Bahl; A Metin Gülmezoglu Journal: PLoS Med Date: 2018-01-16 Impact factor: 11.069